HyperMed Imaging, Inc.
HyperMed Imaging, Inc. is a privately held medical device company that develops and commercializes the HyperView hyperspectral imaging system for non-contact assessment of superficial tissue oxygenation, serving wound care, vascular and reconstructive surgery specialists evaluating perfusion in patients with circulatory compromise.
- Company typePrivate
- Founded2006
- HeadquartersMemphis, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What HyperMed Imaging, Inc. does
HyperMed Imaging, Inc. is a privately held medical device company and the self-described established leader in hyperspectral medical imaging for superficial tissue oximetry. The company has operated in this space since its first-generation OxyVu-1 system received FDA clearance in 2006, and is a wholly controlled subsidiary (by trademark) of SafetySpect, Inc. Its core technology is a proprietary form of hyperspectral imaging that uses visible light directed at the skin surface and a spectrometer to measure light absorption in hemoglobin molecules, differentiating oxygenated from deoxygenated hemoglobin without patient contact and without injectable contrast agents. The product outputs two-dimensional, color-coded maps showing oxyhemoglobin, deoxyhemoglobin and oxygen saturation values, enabling clinicians to assess superficial tissue perfusion adequacy.
The company's commercial product is HyperView, a handheld, battery-operated portable successor to the legacy cart-based OxyVu-1. HyperView received FDA 510(k) clearance in January 2017 and CE Mark approval in April 2018, enabling distribution in the United States and Europe. The device targets wound care specialists, vascular surgeons and reconstructive surgeons who use superficial tissue oxygenation data to inform limb preservation and limb salvage decisions, particularly for patients with diabetes, peripheral vascular disease, and chronic non-healing wounds. The company holds over 60 issued patents and 40+ pending applications worldwide on its hyperspectral medical imaging technology.
HyperMed's business model is hardware sales of the HyperView device through direct enterprise field sales to physicians and healthcare institutions, with marketing presence at vascular, wound care and reconstructive surgery conferences in the US and Europe. Pricing is not publicly disclosed, and the most recent firmographic data indicates the company is not currently offering any medical device for sale. The company is small (1-10 employees), relocated its headquarters from Greenwich, CT to Memphis, TN in February 2015, and has raised approximately $10M in disclosed funding across a 2007 Greenwich Venture Capital Advisors round, a 2014 Series B, and a 2018 round. CEO Mark Darty has led the company since January 2012.
HyperMed Imaging, Inc. firmographics
Firmographics- Name
- HyperMed Imaging, Inc.
- Legal name
- HyperMed Imaging, Inc.
- Website
- https://hypermed.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- HyperMed Imaging, Inc. is a privately held medical device company that develops and commercializes the HyperView hyperspectral imaging system for non-contact assessment of superficial tissue oxygenation, serving wound care, vascular and reconstructive surgery specialists evaluating perfusion in patients with circulatory compromise.
- Ownership category
- akta.pro rank
HyperMed Imaging, Inc. industry classification
Industry- Product category
- Medical Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)
Keywords
Where HyperMed Imaging, Inc. is headquartered
LocationHeadquarters
- HQ city
- Memphis
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
HyperMed Imaging, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Others
Revenue model
- Medical Device Sales: HyperMed generates revenue through the sale of its HyperView hyperspectral imaging medical device. The company commercialized the first generation OxyVu-1 hyperspectral imaging device and has developed a smaller, more portable product (HyperView) which is FDA 510(k) cleared and CE marked for distribution in the US and Europe.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels1 record
HyperMed Imaging, Inc. product offering
Product offeringCore offering
HyperMed Imaging, Inc. develops and commercializes proprietary hyperspectral medical imaging devices for non-invasive assessment of superficial tissue oxygenation. Its flagship HyperView device is a handheld, battery-operated, portable diagnostic imaging system that uses visible light and a spectrometer to measure light absorption in hemoglobin molecules, producing color-coded maps of oxyhemoglobin, deoxyhemoglobin, and oxygen saturation in superficial tissue without patient contact or injectable contrast.
Product overview
HyperMed Imaging, Inc. is the established leader in medical hyperspectral imaging for superficial tissue oximetry. The company offers two products: the legacy OxyVu-1 (FDA cleared in 2006, cart-based mobile imaging system) and its successor HyperView (FDA 510(k) cleared and CE Mark approved handheld, battery-operated portable device). Both products utilize proprietary hyperspectral imaging technology to assess tissue oxygenation by measuring light absorption in hemoglobin molecules, displaying color-coded maps of oxyhemoglobin, deoxyhemoglobin, and oxygen saturation. The HyperView represents the current commercial focus, being smaller, faster, and more portable than its predecessor.
Differentiator
Problem solved
Functional benefit
Brands
- OxyVu-1: First generation hyperspectral imaging device, FDA cleared in 2006, cart-based mobile imaging system no longer being produced or sold.
- HyperView
Products and services
- HyperView A handheld, battery-operated, portable diagnostic imaging device for assessing tissue oxygenation non-invasively without patient contact. Reports oxygen saturation (O2Sat), oxyhemoglobin level (Oxy), and deoxyhemoglobin level (Deoxy) in superficial tissue through proprietary hyperspectral imaging. FDA 510(k) cleared and CE Mark approved for distribution in the US and Europe.
- OxyVu-1 First-generation cart-based hyperspectral imaging system FDA cleared in 2006 for assessing oxyhemoglobin, deoxyhemoglobin, and oxygen saturation in superficial tissue. Legacy product no longer being produced or sold; replaced by the handheld HyperView device.
Companies that use HyperMed Imaging, Inc.
Customer profileSegments2 records
Ideal customer profiles1 record
HyperMed Imaging, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
HyperMed Imaging, Inc. partnerships and signals
Strategic signalScale indicators3 records
Recent moves7 records
Expansion highlights5 records
HyperMed Imaging, Inc. competitors and assessment
Company assessmentMarket position
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
HyperMed Imaging, Inc. social profiles
Digital presenceHyperMed Imaging, Inc. compliance and trust
Trust signalCompliance3 records
HyperMed Imaging, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
HyperMed Imaging, Inc. leadership team
Management profileNumber of profiles
Profiles3 records
HyperMed Imaging, Inc. funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HyperMed Imaging, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HyperMed Imaging, Inc.
What does HyperMed Imaging, Inc. do?
HyperMed Imaging, Inc. develops and commercializes proprietary hyperspectral medical imaging devices for non-invasive assessment of superficial tissue oxygenation. Its flagship HyperView device is a handheld, battery-operated, portable diagnostic imaging system that uses visible light and a spectrometer to measure light absorption in hemoglobin molecules, producing color-coded maps of oxyhemoglobin, deoxyhemoglobin, and oxygen saturation in superficial tissue without patient contact or injectable contrast.
Is HyperMed Imaging, Inc. a public or private company?
HyperMed Imaging, Inc. is a private company. It is classified as corporate owned and is currently operating.
When was HyperMed Imaging, Inc. founded?
HyperMed Imaging, Inc. was founded in 2006. It employs 1 to 10 people.
Where is HyperMed Imaging, Inc. based?
HyperMed Imaging, Inc. is headquartered in Memphis, United States, in the North America region.
How does HyperMed Imaging, Inc. make money?
One revenue line is on record: medical Device Sales.
Does HyperMed Imaging, Inc. have an API?
No public API is recorded for HyperMed Imaging, Inc..
What industry is HyperMed Imaging, Inc. in?
HyperMed Imaging, Inc.'s product category is Medical Imaging Devices. Its primary akta.pro industry code is HLAHACAD, Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry). Its NAICS code is 334510 and its SIC code is 3841.